Koers Cell Therapeutics Inc Nasdaq
Aandelen
US1509348835
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
2023 | Sobi rondt overname van CTI BioPharma af voor $1,7 miljard | MT |
2023 | Swedish Orphan Biovitrum rondt bod op CTI BioPharma af | MT |
Recentste transcriptie over Cell Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20-03-17 |
David Kirske
DFI | Director of Finance/CFO | 69 | 01-08-17 |
John Volpone
HRO | Human Resources Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20-03-17 |
Laurent Fischer
CHM | Chairman | 60 | 21-07-17 |
David Parkinson
BRD | Director/Board Member | 73 | 05-06-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,17% | 42,19 mld. | |
+10,92% | 42,24 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,23% | 24,63 mld. | |
-24,79% | 18,2 mld. | |
+26,69% | 12,01 mld. | |
-3,13% | 11,76 mld. | |
+6,57% | 10,4 mld. |
- Beurs
- Aandelen
- Koers CTIC
- Koers